Perimenopause vs Menopause: Which Hormone Tests Matter Most?

You’ve been sleeping badly. Your periods have become unpredictable. You feel irritable for reasons you can’t quite explain. Sound familiar? For millions of women between the ages of 35 and 55, these experiences mark the beginning of one of the most significant hormonal transitions of their lives — and yet most are never quite sure whether what they’re experiencing is perimenopause, menopause, or something else entirely.

The good news: a simple set of blood tests can tell you exactly where you are in that transition, so you can stop guessing and start managing your health with clarity.

Perimenopause vs menopause: what’s the actual difference?

Perimenopause is the transitional phase leading up to menopause. It can begin as early as your mid-30s but most commonly starts in your 40s. During this phase, your ovaries gradually produce less estrogen and progesterone. Periods become irregular, symptoms fluctuate, and hormone levels shift — sometimes dramatically — from one month to the next.

Menopause is officially confirmed when you have gone 12 consecutive months without a period. After that point, you are considered postmenopausal. Hormone levels stabilise at a consistently lower level, but the health implications — for bone density, cardiovascular health, and mood — continue long term.

The challenge is that symptoms of both stages overlap heavily. Hot flashes, brain fog, poor sleep, and mood changes can appear years before menopause is confirmed. This is precisely why relying on symptoms alone is unreliable — and why testing matters.

Your body is sending signals — these tests decode them

Most women spend months — sometimes years — cycling through GP appointments, mood journals, and Google searches before anyone suggests a hormone panel. The frustration isn’t just the symptoms. It’s not knowing which stage you’re in and therefore not knowing what to do next.

These six tests change that.

FSH (Follicle-Stimulating Hormone) — the headline number

Think of FSH as your brain’s way of shouting at your ovaries. As ovarian function declines, FSH rises — the body’s attempt to compensate. A consistently elevated FSH above 40 mIU/mL is the clearest clinical signal of menopause. In perimenopause it rises, but fluctuates — which is why one normal reading doesn’t rule anything out, and why testing more than once often tells a fuller story.

LH (Luteinising Hormone) — FSH’s partner

LH follows the same upward trend as FSH as the ovaries slow down. Measuring both together sharpens the picture significantly — particularly useful when results sit in an ambiguous range.

Estradiol (E2) — the one most women have heard of

This is the main estrogen your ovaries produce, and its decline is behind most of the symptoms women associate with this transition — hot flashes, vaginal dryness, poor sleep, and mood instability. Low estradiol alongside high FSH is a strong indicator of menopause. In perimenopause, levels are erratic, which explains why you can feel completely fine one month and floored the next.

AMH (Anti-Müllerian Hormone) — the early warning test

AMH measures ovarian reserve — how many viable eggs remain. Its biggest advantage is consistency: unlike most hormones, AMH doesn’t fluctuate with your cycle, so it can be tested on any day of the month and still give a reliable reading. For women under 45 experiencing symptoms, a low AMH is often the first objective sign that perimenopause has begun — sometimes years before periods become irregular.

Progesterone — the overlooked one

While estrogen gets most of the attention, progesterone often drops first. Its decline is closely linked to the anxiety, poor sleep, and heavy or irregular periods that tend to appear early in perimenopause. Testing progesterone on the correct day of your cycle — typically day 21 if you’re still menstruating — adds a dimension most standard panels miss.

TSH (Thyroid-Stimulating Hormone) — the essential check that’s routinely skipped

This is the test most commonly left off the list — and the omission matters. Hypothyroidism produces a near-identical symptom profile to perimenopause: fatigue, weight gain, brain fog, mood changes, and cycle disruption. Without testing TSH alongside the other markers, there’s no way to know whether you’re dealing with one condition, the other, or both at the same time. You can explore individual thyroid and hormone tests at Lotus Azure — it’s not an optional extra, it’s a necessary baseline.

When should you get tested?

If you are over 35 and experiencing irregular periods, unexplained mood changes, disrupted sleep, or hot flashes — don’t wait for symptoms to worsen. Testing earlier gives you a baseline to track changes over time.

If you are still cycling, the best time to test FSH, LH, and estradiol is on days 2–5 of your period. AMH and TSH can be tested at any point. A doctor consultation before testing can help determine which specific markers are most relevant for your symptoms and age.

How Lotus Azure can help

Lotus Azure offers dedicated female hormone check-up packages designed specifically for women navigating perimenopause and menopause, including options for both standard hormone panels and advanced multi-marker assessments. Results are processed through our in-house ISO 15189 accredited laboratory, with same-day reporting available for most tests.

For women over 60, our Golden Years Wellness Program takes a broader approach to long-term health — combining hormone assessment with cardiovascular, metabolic, and bone health screening in a single visit.

Understanding your hormones is the first step to managing this transition on your terms. Book your hormone test today —same-day results available.

For more information, contact:

The Lotus Azure Clinic
☎️ Tel: 02-117-1801
💚 Line: https://line.me/ti/p/~thelotusazure
💬 Website: https://thelotusazure.com/
📍 Address: 89 Surin Building, 2nd Floor, Soi Wat Thong Thammachart, Chiang Mai Road, Khlong San, Bangkok 10600, Thailand
https://maps.app.goo.gl/TJHSSexneTYBW8ta7

Add a comment

Your email address will not be published. Required fields are marked *